F sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant activation of PI3K/Akt
F sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant activation of PI3K/Akt pathway, stemness and the epithelialmesenchymal transition.16,50 It is sensible for clinical therapy to understand the…